Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMX6GFR)

Drug Name

Omega interferon Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Discontinued in Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Interferon alpha/beta receptor 1 (IFNAR1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
EMZ701	DMDEL3F	Hepatitis B virus infection	1E51.0	Phase 2	[3]
MEDI-546	DMPKWR3	Ovarian cancer	2C73	Phase 2	[4]
R-IFN-1a	DMO9QB8	Hepatitis C virus infection	1E51.1	Phase 2	[5]
Belerofon	DM9R0VA	Hepatitis C virus infection	1E51.1	Phase 1	[6]
BLX-883	DMR7WYX	Hepatitis C virus infection	1E51.1	Discontinued in Phase 1	[7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interferon alpha/beta receptor 1 (IFNAR1)	TTSYFMA	INAR1_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005492)
2	Human interferon omega--a review. Mult Scler. 1995;1 Suppl 1:S44-7.
3	Patent EP2766021 A1.
4	Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody. MAbs. 2015;7(2):428-39.
5	Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b. J Neurol Sci.1999 Oct 15;168(2):131-6.
6	WO patent application no. 2009,0153,36, Controlled release interferon drug products and treatment of hcv infection using same.
7	Patent CN103536906 A.